DJO Global reports growth in second quarter of 2013

DJO Global has published its financial report for the second quarter of 2013, during which it achieved year-on-year growth of 3.1 percent.

The medical technology firm's net sales total for the period came to $294.7 million (193.39 million pounds), with the majority of the company's business divisions experiencing improvements.

Its surgical implant and international teams performed particularly strongly, thus helping to offset the difficult trading conditions experienced by its recovery sciences segment, the performance of which will be stimulated by product introductions taking place later this year.

The company has achieved net sales of $573.8 million for the six months ending June 29th 2013, reflecting year-on-year growth of 1.6 percent.

Mike Mogul, DJO's president and chief executive officer, said: "We continue to be very pleased with the revenue growth contributed by our recent new product launches and other commercial initiatives."

This comes after the firm announced the appointment of Sharon Wolfington from Stryker as the new president of its recovery sciences division last month.